SOLTI-1710 PROMETEO II: Palbociclib in combination with letrozole in patients with hormone receptor-positive (HR+)/HER2-negative residual disease after standard neoadjuvant chemotherapy (NAC)

Simple item page
dc.conference.dateMAY 23-24, 2020
dc.conference.titleESMO Breast Cancer Virtual Meeting
dc.contributor.authorCiruelos, E. M.
dc.contributor.authorGonzalez-Farre, X.
dc.contributor.authorPerello, A.
dc.contributor.authorAlba, E.
dc.contributor.authorPalacios-Ozores, P.
dc.contributor.authorSalvador-Bofil, J.
dc.contributor.authorMerino, M.
dc.contributor.authorVillagrasa, P.
dc.contributor.authorCeliz, P.
dc.contributor.authorPascual, T.
dc.contributor.authorPrat, A.
dc.contributor.authorPernas Simon, S.
dc.contributor.authoraffiliation[Ciruelos, E. M.] Hosp 12 Octubre, Dept Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Gonzalez-Farre, X.] Hosp Gen Cataluna, Dept Med Oncol, San Cugat Del Valles, Spain
dc.contributor.authoraffiliation[Perello, A.] Hosp Univ Son Espases, Dept Med Oncol, Palma De Mallorca, Spain
dc.contributor.authoraffiliation[Alba, E.] Hosp Virgen de la Victoria, Dept Med Oncol, Malaga, Spain
dc.contributor.authoraffiliation[Palacios-Ozores, P.] Hosp Clin Univ Santiago, Dept Med Oncol, Santiago De Compostela, Spain
dc.contributor.authoraffiliation[Salvador-Bofil, J.] Hosp Virgen del Rocio, Dept Med Oncol, Seville, Spain
dc.contributor.authoraffiliation[Merino, M.] Hosp Univ Infanta Sofia, Dept Med Oncol, San Sebastian Los Reyes, Spain
dc.contributor.authoraffiliation[Villagrasa, P.] SOLTI Breast Canc Res Grp, Dept Sci, Barcelona, Spain
dc.contributor.authoraffiliation[Celiz, P.] SOLTI Breast Canc Res Grp, Dept Sci, Barcelona, Spain
dc.contributor.authoraffiliation[Pascual, T.] SOLTI Breast Canc Res Grp, Dept Sci, Barcelona, Spain
dc.contributor.authoraffiliation[Prat, A.] Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain
dc.contributor.authoraffiliation[Pernas Simon, S.] Inst Catala Oncol, Dept Med Oncol, Lhospitalet De Llobregat, Spain
dc.contributor.funderPfizer
dc.date.accessioned2025-01-07T15:23:21Z
dc.date.available2025-01-07T15:23:21Z
dc.date.issued2020-05-01
dc.identifier.doi10.1016/j.annonc.2020.03.215
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttp://www.annalsofoncology.org/article/S0923753420362943/pdf
dc.identifier.urihttps://hdl.handle.net/10668/27095
dc.identifier.wosID538879300099
dc.issue.number2
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Virgen de la Victoria
dc.organizationSAS - Hospital Universitario Virgen del Rocío
dc.page.numberS53-S53
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titleSOLTI-1710 PROMETEO II: Palbociclib in combination with letrozole in patients with hormone receptor-positive (HR+)/HER2-negative residual disease after standard neoadjuvant chemotherapy (NAC)
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number31
dc.wostypeMeeting Abstract

Files

Collections

SAS - Hospital Universitario Virgen de la Victoria
SAS - Hospital Universitario Virgen del Rocío

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía